112 related articles for article (PubMed ID: 22729106)
1. Clostridium botulinum type E toxins bind to Caco-2 cells by a different mechanism from that of type A toxins.
Zhang K; Yamamoto Y; Suzuki T; Yokota K; Ma S; Ni Nengah Dwi Fatmawati ; Oguma K
Acta Med Okayama; 2012; 66(3):253-61. PubMed ID: 22729106
[TBL] [Abstract][Full Text] [Related]
2. [Structure and function of botulinum toxin].
Fujii N
Hokkaido Igaku Zasshi; 1995 Jan; 70(1):19-28. PubMed ID: 7744367
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of functional subunits of Clostridium botulinum type A progenitor toxin involved in binding to intestinal microvilli and erythrocytes.
Fujinaga Y; Inoue K; Nomura T; Sasaki J; Marvaud JC; Popoff MR; Kozaki S; Oguma K
FEBS Lett; 2000 Feb; 467(2-3):179-83. PubMed ID: 10675534
[TBL] [Abstract][Full Text] [Related]
4. Production of anti-neurotoxin antibody is enhanced by two subcomponents, HA1 and HA3b, of Clostridium botulinum type B 16S toxin-haemagglutinin.
Lee JC; Yokota K; Arimitsu H; Hwang HJ; Sakaguchi Y; Cui J; Takeshi K; Watanabe T; Ohyama T; Oguma K
Microbiology (Reading); 2005 Nov; 151(Pt 11):3739-3747. PubMed ID: 16272395
[TBL] [Abstract][Full Text] [Related]
5. Molecular characterization of binding subcomponents of Clostridium botulinum type C progenitor toxin for intestinal epithelial cells and erythrocytes.
Fujinaga Y; Inoue K; Watarai S; Sakaguchi Y; Arimitsu H; Lee JC; Jin Y; Matsumura T; Kabumoto Y; Watanabe T; Ohyama T; Nishikawa A; Oguma K
Microbiology (Reading); 2004 May; 150(Pt 5):1529-1538. PubMed ID: 15133114
[TBL] [Abstract][Full Text] [Related]
6. Molecular construction of Clostridium botulinum type A toxins.
Sugii S; Sakaguchi G
Infect Immun; 1975 Dec; 12(6):1262-70. PubMed ID: 54335
[TBL] [Abstract][Full Text] [Related]
7. The haemagglutinin of Clostridium botulinum type C progenitor toxin plays an essential role in binding of toxin to the epithelial cells of guinea pig small intestine, leading to the efficient absorption of the toxin.
Fujinaga Y; Inoue K; Watanabe S; Yokota K; Hirai Y; Nagamachi E; Oguma K
Microbiology (Reading); 1997 Dec; 143 ( Pt 12)():3841-3847. PubMed ID: 9421908
[TBL] [Abstract][Full Text] [Related]
8. Hemagglutinin gene shuffling among Clostridium botulinum serotypes C and D yields distinct sugar recognition of the botulinum toxin complex.
Miyata K; Suzuki T; Hayashi S; Miyashita S; Ohyama T; Niwa K; Watanabe T; Sagane Y
Pathog Dis; 2015 Oct; 73(7):. PubMed ID: 26223883
[TBL] [Abstract][Full Text] [Related]
9. Human milk SIgA binds to botulinum type B 16S toxin and limits toxin adherence on T84 cells.
Matsumura T; Fujinaga Y; Jin Y; Kabumoto Y; Oguma K
Biochem Biophys Res Commun; 2007 Jan; 352(4):867-72. PubMed ID: 17156748
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of the endopeptidase activity of purified botulinum neurotoxins A and E by an isolated component of the native neurotoxin associated proteins.
Sharma SK; Singh BR
Biochemistry; 2004 Apr; 43(16):4791-8. PubMed ID: 15096048
[TBL] [Abstract][Full Text] [Related]
11. Purification and some properties of progenitor toxins of Clostridium botulinum type B.
Kozaki S; Sakaguchi S; Sakaguchi G
Infect Immun; 1974 Oct; 10(4):750-6. PubMed ID: 4214781
[TBL] [Abstract][Full Text] [Related]
12. The C-terminal heavy-chain domain of botulinum neurotoxin a is not the only site that binds neurons, as the N-terminal heavy-chain domain also plays a very active role in toxin-cell binding and interactions.
Ayyar BV; Aoki KR; Atassi MZ
Infect Immun; 2015 Apr; 83(4):1465-76. PubMed ID: 25624352
[TBL] [Abstract][Full Text] [Related]
13. Multivalency effects of hemagglutinin component of type B botulinum neurotoxin complex on epithelial barrier disruption.
Amatsu S; Matsumura T; Yutani M; Fujinaga Y
Microbiol Immunol; 2018 Feb; 62(2):80-89. PubMed ID: 29266585
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of a novel botulinum neurotoxin type H gene.
Dover N; Barash JR; Hill KK; Xie G; Arnon SS
J Infect Dis; 2014 Jan; 209(2):192-202. PubMed ID: 24106295
[TBL] [Abstract][Full Text] [Related]
15. Binding and transcytosis of botulinum neurotoxin by polarized human colon carcinoma cells.
Maksymowych AB; Simpson LL
J Biol Chem; 1998 Aug; 273(34):21950-7. PubMed ID: 9705335
[TBL] [Abstract][Full Text] [Related]
16. Sialic acid-dependent binding and transcytosis of serotype D botulinum neurotoxin and toxin complex in rat intestinal epithelial cells.
Niwa K; Yoneyama T; Ito H; Taira M; Chikai T; Kouguchi H; Suzuki T; Hasegawa K; Miyata K; Inui K; Ikeda T; Watanabe T; Ohyama T
Vet Microbiol; 2010 Mar; 141(3-4):312-20. PubMed ID: 19786330
[TBL] [Abstract][Full Text] [Related]
17. Molecular composition of the 16S toxin produced by a Clostridium botulinum type D strain, 1873.
Nakajima H; Inoue K; Ikeda T; Fujinaga Y; Sunagawa H; Takeshi K; Ohyama T; Watanabe T; Inoue K; Oguma K
Microbiol Immunol; 1998; 42(9):599-605. PubMed ID: 9802560
[TBL] [Abstract][Full Text] [Related]
18. Crystal structure of the HA3 subcomponent of Clostridium botulinum type C progenitor toxin.
Nakamura T; Kotani M; Tonozuka T; Ide A; Oguma K; Nishikawa A
J Mol Biol; 2009 Jan; 385(4):1193-206. PubMed ID: 19071137
[TBL] [Abstract][Full Text] [Related]
19. Clostridium botulinum serotype D neurotoxin and toxin complex bind to bovine aortic endothelial cells via sialic acid.
Yoneyama T; Miyata K; Chikai T; Mikami A; Suzuki T; Hasegawa K; Ikeda T; Watanabe T; Ohyama T; Niwa K
FEMS Immunol Med Microbiol; 2008 Dec; 54(3):290-8. PubMed ID: 18801042
[TBL] [Abstract][Full Text] [Related]
20. Clostridium botulinum type A haemagglutinin-positive progenitor toxin (HA(+)-PTX) binds to oligosaccharides containing Gal beta1-4GlcNAc through one subcomponent of haemagglutinin (HA1).
Inoue K; Fujinaga Y; Honke K; Arimitsu H; Mahmut N; Sakaguchi Y; Ohyama T; Watanabe T; Inoue K; Oguma K
Microbiology (Reading); 2001 Apr; 147(Pt 4):811-819. PubMed ID: 11283277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
